🇺🇸 FDA
Pipeline program

volanesorsen

ISIS 304801-CS17

Phase 3 small_molecule terminated

Quick answer

volanesorsen for Familial Partial Lipodystrophy is a Phase 3 program (small_molecule) at IONIS PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).

Program details

Company
IONIS PHARMACEUTICALS INC
Indication
Familial Partial Lipodystrophy
Phase
Phase 3
Modality
small_molecule
Status
terminated

Clinical trials